Type
Internal restructuring
Country
Belgium
Region
Région Wallonne; Prov. Brabant Wallon; Arr. Nivelles
Location of affected unit(s)
Eigenbrakel
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

88 - 90 jobs
Number of planned job losses
Job loss
Announcement Date
13 March 2019
Employment effect (start)
1 April 2019
Foreseen end date

Description

Baxter International, a multinational developer and manufacturer of pharmaceutical products, has announced it will dismiss 88-90 employees at its facility in Eigenbrakel, south of Brussels. The restructurings are part of an effort by the company management to improve competitiveness by increasing efficiency. Mainly white collar workers within the R&D department and International Support will be affected.


Sources

Citation

Eurofound (2019), Baxter, Internal restructuring in Belgium, factsheet number 97363, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/97363.